Effects of Fusu mixture (Wen-Shen-Qian-Yang Method) on sepsis-induced acute respiratory distress syndrome
- Conditions
- Acute lung injury with sepsis
- Registration Number
- ITMCTR1900002812
- Lead Sponsor
- Affiliated Hospital of Chengdu University of traditional Chinese Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- Not specified
(1) The patient's aged 18-80 years;
(2) The course of disease is within 12-48 hours, which meets the diagnostic criteria for sepsis and acute lung injury [28,29,30];
(3) Oxygenation index (PaO2 / FiO2) <=200 at ARDS;
(4) Patients with mechanical ventilation;
(5) The study complies with the Helsin Declaration and Chinese clinical trial research regulations. The patient or his family knows the research content and voluntarily signs the informed consent form.
(1) pregnant and lactating women;
(2) Those who are allergic to the drugs used in the program;
(3) Those with surgical indications;
(4) Patients with other serious physical diseases, AIDS, and malignant tumors;
(5) Patients who are expected to die or give up active rescue within 12 hours of entering the ICU and are unwilling to undergo conventional supportive treatment by Western medicine;
(6) Patients with contraindications to femoral artery catheterization, patients with contraindication to central venous catheter placement, and patients with contraindications to blood transfusion
(7) Patients with chronic heart failure or end-stage multiple organ failure;
(8) currently participating in other drug researchers;
(9) An employee of the research site or a family member of an employee of the research site.
Study & Design
- Study Type
- Interventional study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method IS score;No ventilator days;Coagulation;Indicators of inflammatory response;Indicators of lung injury;Biochemical Indicators;RASS score;APACHEII score;28-day mortality;SOFA score;Molecular biological marker lncRNA;
- Secondary Outcome Measures
Name Time Method